Unknown

Dataset Information

0

Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation.


ABSTRACT: The current performance of nature compounds in antitumor field is gradually attracted more and more attention, we discovered a nature active ingredient alizarin possess potent natural reductive NF-κB activity to against pancreatic cancer. However, the preclinical pharmacology and therapeutic effect, and the underlying mechanisms of alizarin in inhibiting pancreatic cancer are still unclear. After high-throughput screening, this is the first report that alizarin can induce a potent inhibitory effect against pancreatic cancer cells. Alizarin induced cell cycle arrest and promoted cell apoptosis by inhibiting TNF-α-stimulated NF-κB activity and nuclear translocation, and inactivated its related TNF-α-TAK1-NF-κB signaling cascade followed by downregulation of NF-κB target genes involved in cell apoptosis (Bcl-2, Bcl-xL, XIAP) and in the cell cycle and growth (cyclin D, c-myc). Due to the abrogation of NF-κB activity, combination of alizarin and gemcitabine exerted a better inhibitory effect on pancreatic cancer. In summary, natural component alizarin, inhibited cell proliferation and induced apoptosis in vitro and in vivo through targeting of the NF-κB signaling cascade with minimal toxicity, which combine with gemcitabine, can significantly enhance the antitumor capability, playing a synergistic effect. Therefore, alizarin may play a role in reversing gemcitabine resistance caused by overactivated NF-κB in clinical application in the future.

SUBMITTER: Xu Z 

PROVIDER: S-EPMC9066114 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation.

Xu Zihang Z   Hou Yifei Y   Zou Chunpu C   Liang Haibin H   Mu Jiasheng J   Jiao Xiaoning X   Zhu Yangzhuangzhuang Y   Su Lin L   Liu Mingxi M   Chen Xiao X   Qian Chunmei C   Zhu Xiandan X   Gong Wei W   Dong Qian Q   Zhang Fei F  

International journal of biological sciences 20220328 7


The current performance of nature compounds in antitumor field is gradually attracted more and more attention, we discovered a nature active ingredient alizarin possess potent natural reductive NF-κB activity to against pancreatic cancer. However, the preclinical pharmacology and therapeutic effect, and the underlying mechanisms of alizarin in inhibiting pancreatic cancer are still unclear. After high-throughput screening, this is the first report that alizarin can induce a potent inhibitory eff  ...[more]

Similar Datasets

| S-EPMC6437768 | biostudies-literature
| S-EPMC4929440 | biostudies-literature
| S-EPMC11317417 | biostudies-literature
| S-EPMC3613409 | biostudies-literature
| S-EPMC4446323 | biostudies-literature
| S-EPMC7948076 | biostudies-literature
| S-EPMC5599518 | biostudies-literature
| S-EPMC4632290 | biostudies-other
2020-08-08 | GSE155860 | GEO
| S-EPMC8610585 | biostudies-literature